Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma - Wikidata - awgldk - TriplyDB

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

http://www.wikidata.org/entity/Q26767169

about

Radioresistance of Brain Tumors Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy MiR-10b decreases sensitivity of glioblastoma cells to radiation by targeting AKT.MicroRNA‑376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1.DNM3, p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme.Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study.Silencing LDHA inhibits proliferation, induces apoptosis and increases chemosensitivity to temozolomide in glioma cells.

P2860

Q26752579-12F6675F-134B-4230-941D-6A57A0FB26E8 Q37301832-7474DE24-48E4-46C2-A3CA-2527393E18C6 Q42534830-FC914757-319D-47BE-900C-5A5D3D1701B5 Q47276495-13794900-BEA7-42E0-B299-45B1669A1891 Q49956296-C4BF7081-AB58-4CD0-9396-ED74689A7DAB Q52571345-204EB030-807E-47B3-8A1A-C7A4A50C1E74 Q52649731-F93AC6A5-C602-4CD8-8144-16F45D5D4147

P2860

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

http://www.wikidata.org/entity/Q26767169

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@ast

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@en

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@nl

type

label

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@ast

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@en

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@nl

prefLabel

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@ast

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@en

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@nl

P1433

Q26767169-FFF9CEC2-6557-4260-AA15-B1229DB517CB

P1476

Q26767169-1F6A96FB-6597-4C8E-9C0E-59E2099D58D0

P2093

Q26767169-B8278E63-A71A-49AD-A2CE-E43583B508BE

P2860

Q26767169-00A99DC5-67C3-4647-A348-2795D9FF5BDE

Q26767169-1721C876-DC13-470B-BB20-559AE791E69F

Q26767169-18778274-23DF-43D8-B0CD-0A0CB467F169

Q26767169-1D251FA8-1523-4179-9195-849B7678BB09

Q26767169-1DF015BD-BF18-45AF-9970-1EEB43BEAD1D

Q26767169-21503E83-A6B4-4572-9B2A-35DB453B27CB

Q26767169-24AECA7F-B6A1-4EF5-A8BD-AB17C1693810

Q26767169-2C65AE4F-7656-4257-A12F-51AFF9B545CD

Q26767169-3281BCAC-BAB3-4BA0-8F45-2133D7BCB5D8

Q26767169-35135F18-9EB7-46AA-8E01-4EF3235E565B

P304

Q26767169-0F105831-C5EA-4235-9875-50A9F553CE85

P31

Q26767169-0087C5F2-1170-4898-B9B8-83D670C7FB81

P3181

Q26767169-22CBA2E6-9445-46F4-962D-BAE731461135

P356

Q26767169-8A149A8D-E1A5-4E10-A88F-2242D8F8E670

P407

Q26767169-FA49AF58-23C2-494F-8BF9-CE0C3C0E6E1E

P433

Q26767169-B04F6D7A-8A23-4660-9135-B8A2673F3243

P478

Q26767169-11C05AD3-0475-4A1F-AE27-485AB0B18E93

P577

Q26767169-A839CDB2-E1E0-46E5-A249-B40946550107

P698

Q26767169-E3699ED6-C176-4281-AD3C-DCB002ACC384

P932

Q26767169-32D4FDD1-EE5E-42DA-AC2A-9A55DFBDCFD0

P3181

P356

J.ISSN.2305-5839.2016.01.25

P1433

Annals of translational medicine

P1476

Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma

@en

P2093

Divya Khosla

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

The epidemiology of glioma in adults: a "state of the science" review

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Malignant astrocytic glioma: genetics, biology, and paths to treatment

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

P304

54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

492486

http://www.w3.org/2001/XMLSchema#string

P356

10.3978/J.ISSN.2305-5839.2016.01.25

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26904576

http://www.w3.org/2001/XMLSchema#string

P932

4740000

http://www.w3.org/2001/XMLSchema#string